Gretchen J. Darlington
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gretchen J. Darlington has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Nikolai A. Timchenko
Huffington Center on Aging, Baylor College of Medicine, Houston, TX77030, United States
4 shared publicationsAlana L. Welm
Department of Pathology and Huffington Center on Aging, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
2 shared publicationsBonnie L. Burgess-Beusse
Department of Molecular and Human Genetics, Baylor College of Medicine, One Baylor Plaza, Houston, TX, USA
2 shared publicationsAdam Dean
A Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA
1 shared publicationBrian Poindexter
1 shared publication- Daniel Geoffrey Tenen
Harvard Stem Cell Institute, Harvard Medical School, Boston, USA
1 shared publication
Latest Publications
- 1 September 2013
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 134 (9) , 407-415
Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice
- 1 September 2013
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 134 (9) , 407-415
Farnesoid X receptor directly regulates xenobiotic detoxification genes in the long-lived Little mice
- Open Access
- 19 July 2007
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 25 (10) , 2476-2487
Transcriptional Profiling of Bipotential Embryonic Liver Cells to Identify Liver Progenitor Cell Surface Markers
The ability to purify to homogeneity a population of hepatic progenitor cells from adult liver is critical for their characterization prior to any therapeutic application. As a step in this direction, we have used a bipotential liver cell line from 14 days postcoitum mouse embryonic liver to compile a list of cell surface markers expressed specifically by liver progenitor cells. These cells, known as bipotential mouse embryonic liver (BMEL) cells, proliferate in an undifferentiated state and are capable of differentiating into hepatocyte-like and cholangiocyte-like cells in vitro. Upon transplantation, BMEL cells are capable of differentiating into hepatocytes and cholangiocytes in vivo. Microarray and Gene Ontology (GO) analysis of gene expression in the 9A1 and 14B3 BMEL cell lines grown under proliferating and differentiating conditions was used to identify cell surface markers preferentially expressed in the bipotential undifferentiated state. This analysis revealed that proliferating BMEL cells express many genes involved in cell cycle regulation, whereas differentiation of BMEL cells by cell aggregation causes a switch in gene expression to functions characteristic of mature hepatocytes. In addition, microarray data and protein analysis indicated that the Notch signaling pathway could be involved in maintaining BMEL cells in an undifferentiated stem cell state. Using GO annotation, a list of cell surface markers preferentially expressed on undifferentiated BMEL cells was generated. One marker, Cd24a, is specifically expressed on progenitor oval cells in livers of diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate-treated animals. We therefore consider Cd24a expression a candidate molecule for purification of hepatic progenitor cells.Disclosure of potential conflicts of interest is found at the end of this article.
- 19 July 2007
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 25 (10) , 2476-2487
Open AccessTranscriptional Profiling of Bipotential Embryonic Liver Cells to Identify Liver Progenitor Cell Surface Markers
The ability to purify to homogeneity a population of hepatic progenitor cells from adult liver is critical for their characterization prior to any therapeutic application. As a step in this direction, we have used a bipotential liver cell line from 14 days postcoitum mouse embryonic liver to compile a list of cell surface markers expressed specifically by liver progenitor cells. These cells, known as bipotential mouse embryonic liver (BMEL) cells, proliferate in an undifferentiated state and are capable of differentiating into hepatocyte-like and cholangiocyte-like cells in vitro. Upon transplantation, BMEL cells are capable of differentiating into hepatocytes and cholangiocytes in vivo. Microarray and Gene Ontology (GO) analysis of gene expression in the 9A1 and 14B3 BMEL cell lines grown under proliferating and differentiating conditions was used to identify cell surface markers preferentially expressed in the bipotential undifferentiated state. This analysis revealed that proliferating BMEL cells express many genes involved in cell cycle regulation, whereas differentiation of BMEL cells by cell aggregation causes a switch in gene expression to functions characteristic of mature hepatocytes. In addition, microarray data and protein analysis indicated that the Notch signaling pathway could be involved in maintaining BMEL cells in an undifferentiated stem cell state. Using GO annotation, a list of cell surface markers preferentially expressed on undifferentiated BMEL cells was generated. One marker, Cd24a, is specifically expressed on progenitor oval cells in livers of diethyl 1,4-dihydro-2,4,6-trimethyl-3,5-pyridinedicarboxylate-treated animals. We therefore consider Cd24a expression a candidate molecule for purification of hepatic progenitor cells.Disclosure of potential conflicts of interest is found at the end of this article.
- Open Access
- 1 April 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (16) , 16206-16213
CCAAT Enhancer-binding Protein α Is Required for Interleukin-6 Receptor α Signaling in Newborn Hepatocytes
- 1 April 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (16) , 16206-16213
Open AccessCCAAT Enhancer-binding Protein α Is Required for Interleukin-6 Receptor α Signaling in Newborn Hepatocytes
- Open Access
- 1 September 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (37) , 33848-33856
C/EBPα Is Required for Proteolytic Cleavage of Cyclin A by Calpain 3 in Myeloid Precursor Cells
- 1 September 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (37) , 33848-33856
Open AccessC/EBPα Is Required for Proteolytic Cleavage of Cyclin A by Calpain 3 in Myeloid Precursor Cells
- 16 October 2001
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (22) , 12532-12537
C/EBPα is required for differentiation of white, but not brown, adipose tissue
The transcription factor CCAAT enhancer binding protein α (C/EBPα) is expressed at high levels in liver and adipose tissue. Cell culture studies show that C/EBPα is sufficient to trigger differentiation of preadipocytes into mature adipocytes, suggesting a central role for C/EBPα in the development of adipose tissue. C/EBPα knockout mice die within 7–12 h after birth. Defective gluconeogenesis of the liver and subsequent hypoglycemia contribute to the early death of these animals. This short life span impairs investigation of the development of adipose tissue in these mice. To improve the survival of C/EBPα−/− animals, we generated a transgenic line that expresses C/EBPα under the control of the albumin enhancer/promoter. This line was bred into the knockout strain to generate animals that express C/EBPα in the liver but in no other tissue. The presence of the transgene improved survival of C/EBPα−/− animals almost 3-fold. Transgenic C/EBPα−/− animals at 7 days of age show an absence of s.c., perirenal, and epididymal white fat despite excess lipid substrate in the serum, whereas brown adipose tissue is somewhat hypertrophied and shows minimal biochemical alterations. Interestingly, mammary gland fat tissue is present and exhibits normal morphology. The absence of white adipose tissue in many depots in the presence of high serum lipid levels shows that C/EBPα is required for the in vivo development of this tissue. In contrast, brown adipose tissue differentiation is independent of C/EBPα expression. The presence of lipid in brown adipose tissue serves as an internal nutritional control, indicating that neither nutritional intake nor lipoprotein composition is likely responsible for the absence of white fat.
- 16 October 2001
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (22) , 12532-12537
C/EBPα is required for differentiation of white, but not brown, adipose tissue
The transcription factor CCAAT enhancer binding protein α (C/EBPα) is expressed at high levels in liver and adipose tissue. Cell culture studies show that C/EBPα is sufficient to trigger differentiation of preadipocytes into mature adipocytes, suggesting a central role for C/EBPα in the development of adipose tissue. C/EBPα knockout mice die within 7–12 h after birth. Defective gluconeogenesis of the liver and subsequent hypoglycemia contribute to the early death of these animals. This short life span impairs investigation of the development of adipose tissue in these mice. To improve the survival of C/EBPα−/− animals, we generated a transgenic line that expresses C/EBPα under the control of the albumin enhancer/promoter. This line was bred into the knockout strain to generate animals that express C/EBPα in the liver but in no other tissue. The presence of the transgene improved survival of C/EBPα−/− animals almost 3-fold. Transgenic C/EBPα−/− animals at 7 days of age show an absence of s.c., perirenal, and epididymal white fat despite excess lipid substrate in the serum, whereas brown adipose tissue is somewhat hypertrophied and shows minimal biochemical alterations. Interestingly, mammary gland fat tissue is present and exhibits normal morphology. The absence of white adipose tissue in many depots in the presence of high serum lipid levels shows that C/EBPα is required for the in vivo development of this tissue. In contrast, brown adipose tissue differentiation is independent of C/EBPα expression. The presence of lipid in brown adipose tissue serves as an internal nutritional control, indicating that neither nutritional intake nor lipoprotein composition is likely responsible for the absence of white fat.
- 27 March 1999
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 19 (3) , 1695-1704
C/EBPα Regulates Generation of C/EBPβ Isoforms through Activation of Specific Proteolytic Cleavage
C/EBPα and C/EBPβ are intronless genes that can produce several N-terminally truncated isoforms through the process of alternative translation initiation at downstream AUG codons. C/EBPβ has been reported to produce four isoforms: full-length 38-kDa C/EBPβ, 35-kDa LAP (liver-enriched transcriptional activator protein), 21-kDa LIP (liver-enriched transcriptional inhibitory protein), and a 14-kDa isoform. In this report, we investigated the mechanisms by which C/EBPβ isoforms are generated in the liver and in cultured cells. Using an in vitro translation system, we found that LIP can be generated by two mechanisms: alternative translation and a novel mechanism—specific proteolytic cleavage of full-length C/EBPβ. Studies of mice in which the C/EBPα gene had been deleted (C/EBPα−/−) showed that the regulation of C/EBPβ proteolysis is dependent on C/EBPα. The induction of C/EBPα in cultured cells leads to induced cleavage of C/EBPβ to generate the LIP isoform. We characterized the cleavage activity in mouse liver extracts and found that the proteolytic cleavage activity is specific to prenatal and newborn livers, is sensitive to chymostatin, and is completely abolished in C/EBPα−/− animals. The lack of cleavage activity in the livers of C/EBPα−/− mice correlates with the decreased levels of LIP in the livers of these animals. Analysis of LIP production during liver regeneration showed that, in this system, the transient induction of LIP is dependent on the third AUG codon and most likely involves translational control. We propose that there are two mechanisms by which C/EBPβ isoforms might be generated in the liver and in cultured cells: one that is determined by translation and a second that involves C/EBPα-dependent, specific proteolytic cleavage of full-length C/EBPβ. The latter mechanism implicates C/EBPα in the regulation of posttranslational generation of the dominant negative C/EBPβ isoform, LIP.
- 27 March 1999
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 19 (3) , 1695-1704
C/EBPα Regulates Generation of C/EBPβ Isoforms through Activation of Specific Proteolytic Cleavage
C/EBPα and C/EBPβ are intronless genes that can produce several N-terminally truncated isoforms through the process of alternative translation initiation at downstream AUG codons. C/EBPβ has been reported to produce four isoforms: full-length 38-kDa C/EBPβ, 35-kDa LAP (liver-enriched transcriptional activator protein), 21-kDa LIP (liver-enriched transcriptional inhibitory protein), and a 14-kDa isoform. In this report, we investigated the mechanisms by which C/EBPβ isoforms are generated in the liver and in cultured cells. Using an in vitro translation system, we found that LIP can be generated by two mechanisms: alternative translation and a novel mechanism—specific proteolytic cleavage of full-length C/EBPβ. Studies of mice in which the C/EBPα gene had been deleted (C/EBPα−/−) showed that the regulation of C/EBPβ proteolysis is dependent on C/EBPα. The induction of C/EBPα in cultured cells leads to induced cleavage of C/EBPβ to generate the LIP isoform. We characterized the cleavage activity in mouse liver extracts and found that the proteolytic cleavage activity is specific to prenatal and newborn livers, is sensitive to chymostatin, and is completely abolished in C/EBPα−/− animals. The lack of cleavage activity in the livers of C/EBPα−/− mice correlates with the decreased levels of LIP in the livers of these animals. Analysis of LIP production during liver regeneration showed that, in this system, the transient induction of LIP is dependent on the third AUG codon and most likely involves translational control. We propose that there are two mechanisms by which C/EBPβ isoforms might be generated in the liver and in cultured cells: one that is determined by translation and a second that involves C/EBPα-dependent, specific proteolytic cleavage of full-length C/EBPβ. The latter mechanism implicates C/EBPα in the regulation of posttranslational generation of the dominant negative C/EBPβ isoform, LIP.
- Open Access
- 1 February 1999
- Published by Wolters Kluwer Health in Hepatology
- Vol. 29 (2) , 597-601
Ccaat/Enhancer Binding Protein α (C/Ebpα) Is An Important Mediator of Mouse C/Ebpβ Protein Isoform Production
Both CCAAT/enhancer binding protein α (C/EBPα) and C/EBPβ are intronless, yet can create various N–terminally truncated protein products with distinct DNA binding and transactivation potentials. These proteins can be generated via two distinct mechanisms, one translational and the other post–translational. In the translational mechanism, there is alternative translational start site selection of the different AUG codons present in the single messenger RNA (mRNA) species via a process of leaky ribosome scanning. Additionally, a post–translational method of isoform formation, through specific proteolytic cleavage of the full length protein has also been described. In this manuscript, we present evidence that the production of C/EBPβ protein isoforms in the neonatal mouse liver is regulated by C/EBPα. In C/EBPα knockout mice, the predominant C/EBPβ proteins are the larger 38– and 35–kd isoforms, whereas wild–type animals primarily possess the smaller 21– and 14–kd isoforms. These C/EBPα–dependent differences are liver specific, not present in lung or adipose tissues, and present at day 18 of development. Additionally, we show that induction of C/EBPα expression leads to an increase in the production of the 21–kd C/EBPβ isoform in cell culture studies. As the various C/EBPβ protein isoforms have different transcriptional capabilities, it is important to understand the regulation of the production of these isoforms. Our observations suggest a novel role for the C/EBPα transcription factor in this process.
- 1 February 1999
- Published by Wolters Kluwer Health in Hepatology
- Vol. 29 (2) , 597-601
Open AccessCcaat/Enhancer Binding Protein α (C/Ebpα) Is An Important Mediator of Mouse C/Ebpβ Protein Isoform Production
Both CCAAT/enhancer binding protein α (C/EBPα) and C/EBPβ are intronless, yet can create various N–terminally truncated protein products with distinct DNA binding and transactivation potentials. These proteins can be generated via two distinct mechanisms, one translational and the other post–translational. In the translational mechanism, there is alternative translational start site selection of the different AUG codons present in the single messenger RNA (mRNA) species via a process of leaky ribosome scanning. Additionally, a post–translational method of isoform formation, through specific proteolytic cleavage of the full length protein has also been described. In this manuscript, we present evidence that the production of C/EBPβ protein isoforms in the neonatal mouse liver is regulated by C/EBPα. In C/EBPα knockout mice, the predominant C/EBPβ proteins are the larger 38– and 35–kd isoforms, whereas wild–type animals primarily possess the smaller 21– and 14–kd isoforms. These C/EBPα–dependent differences are liver specific, not present in lung or adipose tissues, and present at day 18 of development. Additionally, we show that induction of C/EBPα expression leads to an increase in the production of the 21–kd C/EBPβ isoform in cell culture studies. As the various C/EBPβ protein isoforms have different transcriptional capabilities, it is important to understand the regulation of the production of these isoforms. Our observations suggest a novel role for the C/EBPα transcription factor in this process.
- 1 December 1998
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 18 (12) , 7269-7277
C/EBPα Is Critical for the Neonatal Acute-Phase Response to Inflammation
Members of the C/EBP (CCAAT/enhancer binding protein) family of transcription factors play important roles in mediating the acute-phase response (APR), an inflammatory process resulting from infection and/or tissue damage. Among the C/EBP family of proteins, C/EBPβ and -δ were thought to be the primary mediators of the APR. The function of C/EBPα in the APR has not been fully characterized to date. Here, we investigate the role of C/EBPα in the APR by using neonatal mice that lack C/EBPα expression. Northern blot analysis of acute-phase protein gene expression in neonatal mice treated with purified bacterial lipopolysaccharide or recombinant interleukin 1β as an inflammation stimulus showed a strong APR in wild-type mice, but a response in C/EBPα null animals was completely lacking. The C/EBPα knockout and wild-type mice demonstrated elevations in C/EBPβ and -δ mRNA expression and DNA binding as well as increased DNA binding of NF-κB, all of which are known to be important in the APR. Null mice, however, failed to activate STAT3 binding in response to lipopolysaccharide. Our results provide the first evidence that C/EBPα is absolutely required for the APR in neonatal mice, is involved in STAT3 regulation, and cannot be compensated for by other C/EBP family members.
- 1 December 1998
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 18 (12) , 7269-7277
C/EBPα Is Critical for the Neonatal Acute-Phase Response to Inflammation
Members of the C/EBP (CCAAT/enhancer binding protein) family of transcription factors play important roles in mediating the acute-phase response (APR), an inflammatory process resulting from infection and/or tissue damage. Among the C/EBP family of proteins, C/EBPβ and -δ were thought to be the primary mediators of the APR. The function of C/EBPα in the APR has not been fully characterized to date. Here, we investigate the role of C/EBPα in the APR by using neonatal mice that lack C/EBPα expression. Northern blot analysis of acute-phase protein gene expression in neonatal mice treated with purified bacterial lipopolysaccharide or recombinant interleukin 1β as an inflammation stimulus showed a strong APR in wild-type mice, but a response in C/EBPα null animals was completely lacking. The C/EBPα knockout and wild-type mice demonstrated elevations in C/EBPβ and -δ mRNA expression and DNA binding as well as increased DNA binding of NF-κB, all of which are known to be important in the APR. Null mice, however, failed to activate STAT3 binding in response to lipopolysaccharide. Our results provide the first evidence that C/EBPα is absolutely required for the APR in neonatal mice, is involved in STAT3 regulation, and cannot be compensated for by other C/EBP family members.
- Open Access
- 1 November 1998
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (46) , 30057-30060
The Role of C/EBP Genes in Adipocyte Differentiation
- 1 November 1998
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 273 (46) , 30057-30060
Open AccessThe Role of C/EBP Genes in Adipocyte Differentiation